Pfizer earnings topped analysts' expectations on Tuesday, helped by demand for its cancer drugs and medicines in emerging markets.» Read More
Allergan has rejected a $47 billion takeover bid by Valeant Pharmaceuticals. The "Squawk on the Street" news team discuss m&a in pharmaceuticals and the IPO market.
*Hillshire to buy Pinnacle Foods for $6.6 billion. NEW YORK, May 12- U.S. stock index futures pointed to a higher open on Monday, putting the S&P 500 within striking distance of record levels, though geopolitical concerns in the Ukraine could cap gains. *In the latest deal news, Hillshire Brands Co agreed to buy Pinnacle Foods Inc for about $6.6 billion.
Geithner tells CNBC the foreign merger situation showed the need for the administration's 2012 corporate tax reform plan that failed to win support.
U.S. stock index futures signaled a higher open on Monday, after the Dow Jones's all-time high close on Friday.
Some of the names on the move ahead of the open.
LONDON, May 12- Pfizer defended the business case behind its plan to acquire AstraZeneca on Monday and questioned the UK drugmaker's ability to stand alone for much longer as the New York- based group's CEO prepared for a grilling from British lawmakers.
*Hillshire to buy Pinnacle Foods for $6.6 billion. NEW YORK, May 12- U.S. stock index futures rose on Monday, putting the S&P 500 within striking distance of record levels, though geopolitical concerns in the Ukraine could cap gains.
Gov. Jack Markell, Governor, (D-Del.), discusses his concerns about Pfizer's proposed acquisition of AstraZeneca.
PFIZER SAYS ITS COMMITMENTS TO UK LEGALLY BINDING@. LONDON, May 12- U.S. drugmaker Pfizer said on Monday its commitments to preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca were legally binding.
LONDON, May 12- U.S. drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers.
CNBC's Catherine Boyle outlines key events this week that will impact Pfizer's struggle to acquire U.K. rival AstraZeneca.
Which M&A deal represents the best value for shareholders?
Pfizer kicked off the most important week to date in its struggle to gain control of U.K. rival AstraZeneca.
LONDON, May 11- British Prime Minister David Cameron said on Sunday he had made very good progress in securing guarantees from Pfizer over the U.S. drugmaker's $106 billion bid to buy AstraZeneca.
Pfizer has launched a fight back against critics of its proposed takeover of AstraZeneca, but did not make any fresh promises on jobs or investment.
*$106 bln Pfizer bid stirs up political storm on job fears. LONDON, May 11- How British is AstraZeneca? With a French chief executive, Swedish chairman, 40 percent of its sales in the United States and 87 percent of its staff overseas, the answer is not simple.
*CEO says UK science a key attraction of AstraZeneca deal. LONDON, May 10- U.S. drugmaker Pfizer fought back on Saturday against criticism that its planned takeover of rival AstraZeneca would damage Britain's science base by saying strong UK research was a key reason for the deal.
LONDON, May 10- Britain is ready for "hard negotiation" to ensure Pfizer sticks to specific promises on jobs and science under the U.S. drugmaker's proposed takeover of AstraZeneca, its finance minister said. "I think it would be extraordinary not to engage with AstraZeneca or Pfizer," George Osborne told BBC radio on Saturday.
Pfizer's $106 billion takeover approach for AstraZeneca is facing mounting scrutiny as senior U.S. politicians weigh in.
Wal-Mart should face lawsuit over alleged Mexico bribery- U.S. judge. Wal-Mart Stores Inc should face a U.S. lawsuit accusing it of defrauding shareholders by concealing suspected corruption at its Mexico operations, even after learning that a damaging media report detailing alleged bribery was being prepared, a federal judge says.